期刊文献+

婴幼儿体外循环期间氨甲环酸血液浓度研究

Study of plasma concentration of tranexamic acid during cardiopulmonary bypass in infants with tetralogy of Fallot
下载PDF
导出
摘要 目的研究婴幼儿法洛四联症(tetralogy of fallot,TOF)根治术体外循环(cardiopulmonary bypaass,CPB)期间应用氨甲环酸(tranexamic acid,TA)的血液浓度。方法 5例先天性TOF患儿,体质量(7.36±2.08)kg,在开胸前应用TA100 mg/kg,单次静脉缓慢注射(>10 min),CPB开始前再次注射100 mg/kg。应用磁共振波谱仪(1H-NMR)方法,检测不同时间段TA的血液浓度。结果 CPB开始前(负荷剂量用药后约20 min)、CPB开始后1 h、手术结束时的血液TA浓度分别为(224.61±195.28)、(509.58±181.57)、(243.95±32.30)μg/mL。CPB开始前与CPB开始后1 h及手术结束时TA浓度比较均无统计学差异(P=0.052、0.83);CPB开始后1 h与手术结束时TA浓度有统计学差异(P=0.02)。结论1H-NMR能够检测出TA的血液浓度。TA大于抑制有高度出血风险可能需要的血液浓度125μg/mL时,提示可降低剂量。 Objective To study the plasma concentration of tranexamic acid(TA) during cardiopulmonary bypass in infants with tetralogy of Fallot(TOF).Methods Five TOF infants with body weight of(7.36±2.08) kg were given an slow intravenous injection of initial dose of TA(100 mg/kg,10 min) before thoracotomy,following by another 100 mg/kg TA before the initiation of cardiopulmonary bypass(CPB).The concentration of TA was measured in blood plasma using 1H-NMR spectroscopy.Results Plasma TA concentrations were(224.61±195.28) μg/mL before CPB(at 20 min after TA administration),(509.58±181.57) μg/mL at 60 min after CPB initiation,and(243.95±32.30) μg/mL at the end of operation,respectively.The plasma TA concentration before CPB was not significantly different from that at 60 min after CPB initiation(P=0.052) and that at the end of operation(P=0.83),but there was significant difference between plasma TA concentration at 60 min after CPB initiation and that at the end of operation(P=0.02).Conclusion A 100 mg/kg initial dose of TA followed by an infusion of 100 mg/kg before the initiation of CPB is sufficient enough to provide an effective plasma concentration,which is higher than 125 μg/mL for patients with high risk of bleeding,indicating the dose of TA can be decreased.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2013年第1期69-72,共4页 Journal of Third Military Medical University
关键词 氨甲环酸 婴幼儿 血药浓度 磁共振波谱仪 tranexamic acid cardiopulmonary bypass infant 1H-NMR
  • 相关文献

参考文献14

二级参考文献30

  • 1杨立新,宛六一,代海平.氨甲环酸氯化钠注射液中Z异构体的控制方法[J].中国生化药物杂志,2004,25(5):311-311. 被引量:1
  • 2易大年 徐光漪.核磁共振波谱在药物分析中的应用 [M].上海:上海科学技术出版社,1985.293-295.
  • 3Comunale ME, Carr JM, Moorman RM, et al. Significance of D-dimer concentrations during and after cardiopulmonary bypass [J]. Cardiothorac Vasc Anes, 1996, 10(5): 477-481.
  • 4Charles W, Philip E, Roy I, et al. D-dimer formation during car diae and noncardiac thoracic surgery [J]. Anesth Analg, 1999,88 (12) :1226.
  • 5Zonis Z, Seear M, Reichert C, et al. The effect of preoperative tranexamic acid on blood loss after cardiac operations in children [J]. Thorac Cardiovasc Surg,1996,111(1):92-97.
  • 6Robert W, Andrew Z, Peter C,et al. The Efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery [J]. Anesth Analg, 1997,84 (11) :990.
  • 7Elena L, John WU, Dana V, et al. Haemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid[J]. Thromb Haemost, 2000,83 (1) : 54-59.
  • 8Michael J, Wayne L, Nancy B, et al. Cardiopulmonary bypass parameters and haemostatic response to cardiopulmonary bypass in infants versus children [J]. Journal of Cardiothoracic and Vascular Anesthesia, 2008, 22(1) :53-59.
  • 9Glyn D, Susan I., Bratton,et al. Factors associated with blood loss and blood product transfusions: A muhivariate analysis in children after open heart surgery [J]. Anesth Analg, 1999, 89 (1):57-64.
  • 10吴福楷,邱涵.HPLC法测定氨甲环酸胶囊的溶出度[J].海峡药学,2007,19(7):50-51. 被引量:1

共引文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部